LLY compared with ALT: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ALTAltimmune, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ALTAltimmune, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ALT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.7%▼−2.33%×0.18

May 13 '26±8.2%▼−1.95%×0.23

= impliedLLY realized, solidALT realized, hatchedOne scale, both sides: full bar = 18%× = |realized| ÷ impliedSource: market data

Q1 FY26

±10.3%

▼−17.92%

×1.74

Q3 FY25±14.3%▲+5.07%×0.36

LLYELI Lilly & Co

1,371.32· pre 1,346.87· delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ALTAltimmune, Inc.

1.95· pre 1.99· delayed

Pre-marketNov 6 '26delayed

Mkt cap$383.2MRevenue$26,000Q4 FY25Revenue$41,000FY25

Compare

Pre-marketNov 6 '26delayed

LLYELI Lilly & Co

ALTAltimmune, Inc.

1,371.32pre 1,346.87delayed

Price

1.95pre 1.99delayed

$1.2T

Mkt cap

$383.2M

Q3 FY26$24.4B

Revenue

$26,000Q4 FY25

FY25$65.2B

Revenue

$41,000FY25

LLY1,371.32vsALT1.95Pre-marketNov 6 '26delayed